Btg Pactual Global Asset Management LTD Halozyme Therapeutics, Inc. Transaction History

Btg Pactual Global Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $137,179 - $192,030	-10,291 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $344,091 - $379,779	-20,629 Reduced 66.72%	10,291 $187,000
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $41,247 - $49,633	-2,445 Reduced 7.33%	30,920 $522,000
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $569,206 - $707,338	33,365 New	33,365 $654,000

541

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.63B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.